反应详情

3-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-5-(5-{3-methyl-3-[(triethylsilyl)oxy]butyl}-2-thienyl)-1H-indole-7-carboxamide (55 mg, 0.1 mmol) was dissolved in tetrahydrofuran (3 mL). Tetrabutylammonium fluoride (1 M in THF, 0.3 mL, 0.3 mmol) was added and the mixture was stirred at rt for 2 h. Additional TBAF (1 M in THF, 0.7 mL, 0.7 mmol) was added, and the mixture was stirred at 45° C. overnight. The reaction mixture was concentrated, re-diluted in dichloromethane (20 mL), and washed with water (20 mL). The organic layer was dried over sodium sulfate and concentrated. The crude product was purified by flash chromatography, eluting with 0-15% methanol in dichloromethane. The residue was then repurified by Gilson HPLC(NH4OH buffer). The product fractions were combined and concentrated in an EZ2 Genevac evaporator, giving 17 mg (40%) of the title compound.

1. stirringthe mixture was stirred at 45° C. overnight
2. concentrationThe reaction mixture was concentrated
3. additionre-diluted in dichloromethane (20 mL)
4. washwashed with water (20 mL)
5. dry with materialThe organic layer was dried over sodium sulfate
6. concentrationconcentrated
7. customThe crude product was purified by flash chromatography
8. washeluting with 0-15% methanol in dichloromethane
9. customThe residue was then repurified by Gilson HPLC(NH4OH buffer)
10. concentrationconcentrated in an EZ2 Genevac evaporator